skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Search for: All records

Creators/Authors contains: "Feng, Zhaoqianqi"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. Abstract Despite multiple new‐drug approvals in recent years, prostate cancer remains a global health challenge because of the prostate cancers are resistant to androgen deprivation therapy. Here, we show that a small D‐phosphopeptide undergoes prostatic acid phosphatase (PAP)‐instructed self‐assembly for inhibiting castration‐resistant prostate cancer (CRPC) cells. Specifically, the installation of phosphate at the C‐terminal of a D‐tripeptide results in the D‐phosphopeptide. Dephosphorylating the D‐phosphopeptide by PAP forms uniform nanofibers that inhibit VCaP, a CRPC cell. A non‐hydrolyzable phosphate analogue of the D‐phosphopeptide, which shares similar self‐assembling properties with the D‐phosphopeptide, confirms that PAP‐instructed assembly is critical for the inhibition of VCaP. This work, for the first time, demonstrates PAP‐instructed self‐assembly of peptides for selective inhibiting CRPC cells. 
    more » « less